Structures by: Diogo H. P.
Total: 14
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0524(2)Å b=16.3826(5)Å c=23.4238(7)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=5.9874(5)Å b=16.1056(15)Å c=23.4443(19)Å
α=90° β=90.04(2)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0018(6)Å b=16.139(2)Å c=23.448(3)Å
α=90.000(7)° β=90.032(7)° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.0587(3)Å b=16.4386(10)Å c=23.3475(14)Å
α=90° β=90° γ=90°
C25H38O5
C25H38O5
Molecular pharmaceutics (2018) 15, 11 5349-5360
a=6.1145(2)Å b=17.2901(6)Å c=22.4334(8)Å
α=90° β=90° γ=90°
[Fe(5-Br-salEen)2]ClO4
[Fe(5BrsalEen)2]ClO4
Chem. Sci. (2016) 7, 7 4251
a=10.3027(4)Å b=14.2644(6)Å c=18.1624(7)Å
α=90° β=90° γ=90°
C22H28Br2ClFeN4O6
C22H28Br2ClFeN4O6
Chem. Sci. (2016) 7, 7 4251
a=11.931(3)Å b=12.170(3)Å c=19.166(5)Å
α=90° β=90° γ=90°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=6.976(2)Å b=11.231(5)Å c=16.290(6)Å
α=82.55(2)° β=78.279(17)° γ=75.166(15)°
C6H4ClNO3
C6H4ClNO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=5.469(2)Å b=10.529(4)Å c=11.795(4)Å
α=90.00° β=97.72(2)° γ=90.00°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=3.7970(10)Å b=7.354(2)Å c=20.905(4)Å
α=90.00° β=90.007(11)° γ=90.00°
C6H5NO3
C6H5NO3
The journal of physical chemistry. B (2009) 113, 43 14291-14309
a=3.804(3)Å b=14.582(7)Å c=10.673(6)Å
α=90.00° β=94.254(18)° γ=90.00°
C24H16
C24H16
The journal of physical chemistry. A (2006) 110, 6 2299-2307
a=7.8270(5)Å b=4.8647(5)Å c=20.2212(16)Å
α=90.000(8)° β=92.791(6)° γ=90.000(7)°
C11H10FeO
C11H10FeO
The journal of physical chemistry. A (2008) 112, 13 2977-2987
a=7.639(6)Å b=10.518(8)Å c=11.300(9)Å
α=90.00° β=90.00° γ=90.00°
C12H14Fe
C12H14Fe
The journal of physical chemistry. A (2008) 112, 13 2977-2987
a=10.954(4)Å b=7.526(3)Å c=12.334(6)Å
α=90.00° β=102.81(2)° γ=90.00°